Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga January 07, 2015 at 08:19 AM EST KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO) shares fell 64.48% to $0.65 in pre-market trading after the company reported top-line ... Read More >> Related Stocks: Eli Lilly Five Prime Thera Micron Technology RPM International Inc